More news about the pandemic

WHO advisory panel is recommending that future COVID vaccines be based on newer variant such as XBB.1

Read full story

As COVID public health emergency ends, ‘whack-a-mole’ virus won’t be easy to track

The U.S. COVID-19 public health emergency comes to an end on Thursday, but the fight against COVID goes on.

Read full story

U.S. to lift most federal COVID-19 vaccine mandates next week

Vaccine requirements for federal workers and federal contractors, as well as foreign air travelers to the U.S., will end May 11.

FDA approves single booster dose of bivalent COVID vaccine for people aged 65 and older or those with immunocompromise

Healthcare Shares Fall; J&J Boosts Earnings Outlook -- Healthcare Roundup

Read full story

What WHO’s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock

The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year.

Read full story

BioNTech Stock Is Falling. Blame the Covid Vaccine Outlook.

The German biotech that partnered with Pfizer to develop a Covid-19 vaccine expects fewer vaccinations and lowered levels of boosting this year.

BioNTech 4Q Rev EUR4.28B >BNTX

Read full story

The stock market hit a pandemic bottom 3 years ago. Here’s how it has performed since then.

It has been three years since the U.S. stock market hit its COVID-19 bottom as the global economy suddenly shut down at the onset of the pandemic in early 2020. 

Read full story

The Bank Turmoil Isn’t Over. What It Means for the Fed Looking Forward.

Moderna’s CEO is faces a Senate grilling over $130 Covid-19 shot, Google expands public access to its ‘Bard’ chatbot, and other news to start your day.

Health Care Up on Rotation Into Financials -- Health Care Roundup

Read full story

WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants

Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.

WHO says independent panel of experts is evaluating evidence on new COVID variants to determine whether vaccines need to be updated

Read full story

Moderna’s stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID.

Moderna Inc.'s stock slid 5% Friday, after the COVID vaccine maker said a trial of a flu-vaccine candidate failed to meet one of its goals.

Read full story

House Republicans launch probe of pandemic’s origins and seek information from Anthony Fauci

House Republicans have launched a probe into the origins of COVID by issuing a series of letters to current and former Biden administration officials.